Oxford Angels NetworkThe Oxford Angels Network is a business angels network for both individual and institutional investors and private companies interested in investing in spinout companies from the University of Oxford. It provides a vehicle from which investors and companies can meet, discuss and invest in the early stages of a University spinout company. Established in 1999, the Oxford Angels Network (OAN) is a not-for-profit company limited by guarantee. We facilitate first-round investment in spinouts from all investors - business angels, seed and venture capitalists and corporate venturing - from the UK and internationally. Oxford Angels Network membership is currently free, and open to investment professionals, private investors and the financial service sector. Membership entitles you to receive:
- business proposals circulated by us on behalf of spinout companies looking for funding;
- invitations to our regular Investment Meetings, at which both early-stage and established spinout companies present their funding opportunities.
|Investor Type||Angel Groups|
|Services Provided||Business Advisors and Mentoring, Cross Border Investment, Incubator / Accelerator, Investor Training, Live Pitch Presentations, Online Showcase|
|Investment Stage||Seed, Start-Up, Early Stage VC|
|Regions Covered||South East|
|Investment Range||Less than £150k, £150k - £250k, £250k - £500k|
|Sectors Considered||Aerospace and Defence, Automobile and Transport, Business Products and Services, Clean Tech and Eco Innovation, Computing and Electronics, Consumer Technology, Creative Arts and Entertainment, Digital Media and Content, Fin Tech, Food and Drink, Healthcare, Med Tech and Digital Health, Internet of Things, Life Sciences, Logistics and Distribution, Materials and Manufacturing, Mobile and Telecoms, Renewables and Energy, Social Impact|
|No. of opportunities selected each year||8-12|
Closing soon – the fourth University of Oxford Innovation Fund
Interest has been strong in the latest UOIF, managed by Parkwalk Advisors. This EIS/SEIS fund allows...
University of Oxford Innovation Fund IV launches
Oxford’s early-stage EIS/SEIS fund returns to take advantage of new benefits to investors in high tech...
Oxford spinouts investment increases 5x in 2016
A total of £52.6m was invested in 21 spinouts in 2016. Oxford Sciences Innovation was a...
Atopix Therapeutics acquired by Chiesi Farmaceutici
Atopix Therapeutics Limited, a UK biotechnology company with roots back to Oxford University, has been acquired...
Oxford announces revised arrangements for spinout companies
A new, standardised approach for the licensing of intellectual property (IP) to spinout companies has been...